Clinical-style sublingual buprenorphine film works in awake rats, giving patient-like drug levels
- Most rodent opioid studies use routes unlike the sublingual film given to patients, so the authors dosed awake male rats with a buprenorphine/naloxone film, with the dose scaled from the human regimen.
- A single dose produced plasma buprenorphine across the range seen in treated patients, measured by LC-MS/MS.
- After three weeks of daily dosing, liver weight dropped, yet serum liver enzymes and liver histology matched controls.
- The route is feasible and tolerated, supporting route-matched preclinical work.
💡 Points Based on the abstract
Matching plasma levels is the easy half. Buprenorphine's value in OUD rests on high mu-receptor occupancy and slow dissociation, and none of that was measured here. Rats also swallow some film, so I'd want a no-naloxone arm to separate sublingual from gut absorption, plus occupancy or behavior readouts, and female animals. Liver weight loss despite clean enzymes deserves a follow-up.